COMP <GO>
ESTA vs ENOV // REVENUE GROWTH (YOY)
Establishment Labs Holdings Inc. (NASDAQ) VS. Enovis Corporation (NYSE) • 15-METRIC TALLY: ESTA 7
— ENOV 3
▲ REVENUE GROWTH (YOY) LEADER: ESTA
LAST: $68.41 (-0.81%) • MKT CAP: $2.04B
revenue-growth
27.10%
LAST: $22.81 (+4.11%) • MKT CAP: $1.32B
revenue-growth
6.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ESTA VS. ENOV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ESTA | ENOV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.30% | 59.80% | +9.50 | ESTA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -15.80% | -32.70% | +16.90 | ESTA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.79% | 1.51% | -4.30 | ENOV | /fcf-yield <GO> |
| Operating Margin | -18.50% | -50.00% | +31.50 | ESTA | /operating-margins <GO> |
| Net Profit Margin | -24.20% | -52.70% | +28.50 | ESTA | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 27.10% | 6.70% | +20.40 | ESTA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.52 | 0.20 | +2.32 | ESTA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | ENOV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.9 | 48.3 | -3.40 | ENOV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.04B | $1.32B | $723.3M | ESTA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ESTA REV | ENOV REV | ESTA GROSS % | ENOV GROSS % | ESTA FCF | ENOV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $211.1M | $2.25B | 69.3% | 59.8% | -$56.9M | $19.9M |
| FY 2024 | $166.0M | $2.11B | 66.0% | 56.0% | -$64.6M | -$67.2M |
| FY 2023 | $165.2M | $1.71B | — | — | -$88.5M | $135.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ESTA // BETA —
ENOV // BETA —